SCHEMBL23486307

SCHEMBL23486307

C=C/C=C\C(=C/C)Nc1ccnnc1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25489239 0.66 KDM4E (0.49) —
SCHEMBL19057796 0.66 TGM2 (0.44) —
SCHEMBL22268029 0.65 GAA (0.42) —
SCHEMBL18721414 0.65 MAP2K2 (0.30) —
SCHEMBL18798818 0.64 FABP3 (0.37) —
SCHEMBL22064123 0.63 NR4A2 (0.49) —
SCHEMBL23486417 0.63 FABP4 (0.46) —
SCHEMBL20143351 0.63 NPC1 (0.46) —
SCHEMBL19403907 0.62 SMN1; SMN2 (0.47) —
SCHEMBL27401064 0.62 KMT2A (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed
Send feedback